ETHAN: A phase II study comparing different endocrine therapies for male breast cancer.

被引：0
|
作者：
Leone, Jose Pablo
Ruddy, Kathryn Jean
Rashid, Naim
Giordano, Sharon H.
Gupta, Gaorav P.
Hilsenbeck, Susan G.
Gucalp, Ayca
Walsh, Elaine M.
Sukumar, Jasmine S.
Makhlin, Igor
Ortiz-Perez, Tamara
Spanheimer, Philip Merle
Calhoun, Benjamin C.
Wolff, Antonio C.
Krop, Ian E.
Thompson, Alastair Mark
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[2] Mayo Clin, Rochester, MN USA
[3] Univ North Carolina Chapel Hill, Dept Biostat, Chapel Hill, NC USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[5] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[6] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX USA
[7] Mem Sloan Kettering Canc Ctr, New York, NY USA
[8] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[9] Univ Penn, Philadelphia, PA USA
[10] Baylor Coll Med, Houston, TX USA
[11] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[12] Yale Canc Ctr, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS632
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase Ib study of abemaciclib with therapies for metastatic breast cancer.
    Tolaney, Sara M.
    Beeram, Muralidhar
    Beck, J. Thaddeus
    Conlin, Alison Katherine
    Dees, Elizabeth Claire
    Dickler, Maura N.
    Helsten, Teresa L.
    Conkling, Paul R.
    Edenfield, William Jeffery
    Richards, Donald A.
    Turner, P. Kellie
    Cai, Na
    Chan, Edward Michael
    Pant, Shubham
    Becerra, Carlos
    Kalinsky, Kevin
    Puhalla, Shannon
    Rexer, Brent Neil
    Burris, Howard A.
    Goetz, Matthew P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Phase II study of perifosine in metastatic or advanced breast cancer.
    Leighl, NB
    Warr, D
    Vandenberg, T
    Dent, S
    Tannock, IF
    Crump, M
    Tozer, R
    Dancey, J
    Moore, MJ
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S67 - S68
  • [3] Endocrine therapies of breast cancer
    Goldhirsch, A
    Gelber, RD
    SEMINARS IN ONCOLOGY, 1996, 23 (04) : 494 - 505
  • [4] Phase II breast cancer chemoprevention study with celecoxib in women at increased risk for breast cancer.
    Arun, B.
    Valero, V.
    Yin, G.
    Babiera, G.
    Murray, J. L.
    Browne, D.
    Gong, Y.
    Cook, E.
    Hortobagyi, G. N.
    Sneige, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 51S - 51S
  • [5] A pilot phase II study of capecitabine in advanced or recurrent breast cancer.
    Saeki T.
    Kimura T.
    Toi M.
    Taguchi T.
    Breast Cancer, 2006, 13 (1) : 49 - 57
  • [6] New endocrine therapies for breast cancer
    Howell, A
    Downey, S
    Anderson, E
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (04) : 576 - 588
  • [7] Novel endocrine therapies in breast cancer
    Klijn, JGM
    SetyonoHan, B
    Bontenbal, M
    Seynaeve, C
    Foekens, J
    ACTA ONCOLOGICA, 1996, 35 (05) : 30 - 37
  • [8] ABC of breast diseases - Medical treatment of early breast cancer. II: endocrine therapy
    Smith, IE
    Chua, S
    BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7533): : 101 - 103
  • [9] Lonidamine plus epirubicin and cyclophosphamide in advanced breast cancer. A phase II study
    Gardin, G
    Barone, C
    Nascimben, O
    Ianniello, G
    Sturba, F
    Contu, A
    Pronzato, P
    Rosso, R
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (01) : 176 - 177
  • [10] Phase II study of gemcitabine (G) and vinorelbine (V) in metastatic breast cancer.
    Donadio, M
    Ritorto, G
    Novarino, A
    Bonazzi, G
    Coccorullo, Z
    Buffoni, L
    Occelli, M
    Bertetto, O
    ANNALS OF ONCOLOGY, 2000, 11 : 31 - 31
12345